Redsense Medical AB (publ) (RDSNF) Ganando

Redsense Medical AB engages in the development and manufacturing of blood loss detection devices. The company is headquartered in Halmstad, Hallands and currently employs 4 full-time employees. The company went IPO on 2015-06-17. The firm is active within the field of hemodialysis. The company operates as a manufacturer of blood loss detection device that is designed to alarm on blood leakage from the venous blood access. The firm's Redsense system consists of an alarm unit, an extension fiber and a non invasive sensor patch. When the sensor patch is placed over the blood access, it detects any blood coming in contact with the sensor. This can occur if the needle is accidentally dislodged or if blood is leaking during dialysis. The Redsense system is designed to alarm when blood reaches the sensor, so the dialysis caregiver or observing person at home, can apply appropriate action when a venous needle dislodges.